Geno

Specialty company developing inhaled drug delivery technologies through its proprietary NO technology

placeLexington, Massachusetts, United States calendar_todayFounded 2006 groups225 employees language genollc.com

Registered entities

Investor mix

3 investors on record; lead investors include The Medicines Company.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon